ZYBT jlzybio.com Net earnings per share growth forecast for next year

Official company branding of Zhengye Bio (ZYBT)

Demand for livestock biosecurity in China supports the stability of Zhengye Biotechnology (ZYBT) through government contracts. This chart on GURU.Markets shows that the change in the consensus earnings per share forecast has reached a point where the value of 0.00 expresses the metric level. Investors should consider the risk of delisting due to US-China trade disputes, despite the high utilization of sterile production lines.

ZYBT - Zhengye Corp Expected earnings per share trend next year over the range 01/08/2025 - 11/17/2026

Metric breakdowns and analytics for Zhengye Biotechnology Co., Ltd. (ZYBT)

- share price and consensus valuation forecast:
Comprehensive company analysis:Zhengye Biotechnology, ZYBT
Finished products of jlzybio.com

The long-term sustainability of Zhengye Biotechnology (ZYBT) is determined by the business's ability to scale net profit amid market volatility. This indicator measures the expected percentage growth in earnings per share by aggregating consensus forecasts from leading analysts. The price action of the projected earnings per share growth target allows for an assessment of market expectations regarding future profitability. For this vaccine manufacturer, this trend confirms the effectiveness of formula control when outsourcing distribution.